Table 3.
Effects of CL-316,243 on EEG SWA in WT and UCP-1 KO mice – statistical results.
| 0.04 mg/kg CL-316,243 – EEG SWA | df | F | p |
|---|---|---|---|
| Genotype | 1,11 | 1.4 | n.s |
| Treatment | 1,11 | 11.5 | <0.05 |
| Treatment × genotype | 1,11 | 1.4 | n.s |
| Time | 11,121 | 11.0 | <0.05 |
| Time × genotype | 11,121 | 0.8 | n.s |
| Treatment × time | 11,121 | 1.5 | n.s. |
| Treatment × time × genotype | 11,121 | 2.0 | <0.05 |
| 0.2 mg/kg CL-316,243 - EEG SWA | df | F | p |
| Genotype | 1,11 | 0.1 | n.s |
| Treatment | 1,11 | 4.4 | n.s |
| Treatment × genotype | 1,11 | 0.1 | n.s |
| Time | 11,121 | 19.0 | <0.05 |
| Time × genotype | 11,121 | 0.5 | n.s |
| Treatment × time | 11,121 | 4.0 | <0.05 |
| Treatment × time × genotype | 11,121 | 1.5 | n.s. |
| 1 mg/kg CL-316,243 - EEG SWA | df | F | p |
| Genotype | 1,10 | 0.4 | n.s. |
| Treatment | 1,10 | 12.0 | <0.05 |
| Treatment × genotype | 1,10 | 0.3 | n.s. |
| Time | 10,110 | 22.3 | <0.05 |
| Time × genotype | 10,110 | 1.2 | n.s. |
| Treatment × time | 10,110 | 3.5 | <0.05 |
| Treatment × time × genotype | 10,110 | 1.8 | n.s. |